Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk ESSA Pharma Inc. per 2025 Jun 30 adalah -29.66 MM.
- Nilai net income untuk ESSA Pharma Inc. per 2025 Jun 30 adalah -25.27 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -29.66 | -25.27 | |
2025-03-31 | -33.40 | -28.50 | |
2024-12-31 | -36.51 | -31.11 | |
2024-09-30 | -34.42 | -28.54 | |
2024-06-30 | -33.88 | -27.67 | |
2024-03-31 | -34.15 | -27.73 | |
2023-12-31 | -31.87 | -25.80 | |
2023-09-30 | -32.13 | -26.58 | |
2023-06-30 | -32.11 | -27.42 | |
2023-03-31 | -32.49 | -28.95 | |
2022-12-31 | -35.74 | -32.75 | |
2022-09-30 | -36.96 | -35.10 | |
2022-06-30 | -39.05 | -37.34 | |
2022-03-31 | -39.11 | -37.26 | |
2021-12-31 | -39.53 | -39.37 | |
2021-09-30 | -37.14 | -36.81 | |
2021-06-30 | -32.36 | -32.80 | |
2021-03-31 | -27.89 | -28.97 | |
2020-12-31 | -25.49 | -25.36 | |
2020-09-30 | -23.52 | -23.45 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.57.
- laba per saham yang terdilusi untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.57.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -0.57 | -0.57 |
2025-03-31 | -0.64 | -0.64 |
2024-12-31 | -0.70 | -0.70 |
2024-09-30 | -0.64 | |
2024-06-30 | -0.63 | -0.63 |
2024-03-31 | -0.63 | -0.63 |
2023-12-31 | -0.59 | -0.59 |
2023-09-30 | -0.60 | |
2023-06-30 | -0.62 | -0.62 |
2023-03-31 | -0.66 | -0.66 |
2022-12-31 | -0.74 | -0.74 |
2022-09-30 | -0.80 | |
2022-06-30 | -0.85 | -0.85 |
2022-03-31 | -0.87 | -0.86 |
2021-12-31 | -0.96 | -0.96 |
2021-09-30 | -0.96 | |
2021-06-30 | -0.95 | -0.95 |
2021-03-31 | -0.98 | -0.98 |
2020-12-31 | -0.99 | -0.99 |
2020-09-30 | -1.04 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk ESSA Pharma Inc. per 2025 Jun 30 adalah -20.88 MM.
- Nilai cash from investing activities untuk ESSA Pharma Inc. per 2025 Jun 30 adalah 20.79 MM.
- Nilai kas dari aktivitas pendanaan untuk ESSA Pharma Inc. per 2025 Jun 30 adalah 0.06 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -20.88 | 20.79 | 0.06 |
2025-03-31 | -22.43 | 16.97 | 0.09 |
2024-12-31 | -22.40 | 79.63 | 0.73 |
2024-09-30 | -22.72 | 91.79 | 0.93 |
2024-06-30 | -23.84 | 70.50 | 0.85 |
2024-03-31 | -23.00 | 69.59 | 0.79 |
2023-12-31 | -22.19 | 6.20 | 0.11 |
2023-09-30 | -19.78 | -3.53 | -0.07 |
2023-06-30 | -22.77 | -6.61 | -0.09 |
2023-03-31 | -24.18 | -17.80 | -0.05 |
2022-12-31 | -26.56 | -43.55 | 0.17 |
2022-09-30 | -28.00 | -53.05 | 0.25 |
2022-06-30 | -27.91 | -49.71 | 0.30 |
2022-03-31 | -28.11 | -37.64 | 0.48 |
2021-12-31 | -27.29 | -46.01 | 141.94 |
2021-09-30 | -25.42 | -35.01 | 141.99 |
2021-06-30 | -22.18 | -56.75 | 187.75 |
2021-03-31 | -19.15 | -56.74 | 187.61 |
2020-12-31 | -17.57 | -21.74 | 45.96 |
2020-09-30 | -16.98 | -21.74 | 41.78 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -2.66.
- p/libro untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah 0.67.
- p/tbv untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah 0.67.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -2.66 | 0.67 | 0.67 |
2025-03-31 | 0.58 | 0.58 | |
2024-12-31 | 0.64 | 0.64 | |
2024-09-30 | -10.33 | 2.22 | 2.22 |
2024-06-30 | -8.29 | 1.72 | 1.72 |
2024-03-31 | -14.67 | 2.69 | 2.69 |
2023-12-31 | -10.96 | 2.00 | 2.00 |
2023-09-30 | -4.98 | 0.91 | 0.91 |
2023-06-30 | -4.20 | 0.78 | 0.78 |
2023-03-31 | -4.05 | 0.82 | |
2022-12-31 | 0.66 | 0.66 | |
2022-09-30 | 0.47 | 0.47 | |
2022-06-30 | -3.74 | 0.78 | 0.78 |
2022-03-31 | -6.93 | 1.46 | 1.46 |
2021-12-31 | -16.78 | 3.18 | 3.18 |
2021-09-30 | -10.74 | 1.76 | 1.76 |
2021-06-30 | |||
2021-03-31 | -8.23 | 1.16 | 1.16 |
2020-12-31 | -7.82 | 2.68 | 2.68 |
2020-09-30 | -8.07 | 2.39 | 2.39 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah 2.74.
- EBIT (3 tahun) / EV untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah 2.68.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 2.74 | 2.68 |
2025-03-31 | 1.29 | 1.22 |
2024-12-31 | 1.21 | 1.23 |
2024-09-30 | -0.14 | -0.15 |
2024-06-30 | -0.20 | -0.23 |
2024-03-31 | -0.08 | -0.10 |
2023-12-31 | -0.10 | -0.13 |
2023-09-30 | -0.28 | -0.33 |
2023-06-30 | -0.38 | -0.43 |
2023-03-31 | -0.40 | -0.41 |
2022-12-31 | -0.66 | -0.60 |
2022-09-30 | -3.00 | -2.62 |
2022-06-30 | -0.70 | -0.58 |
2022-03-31 | -0.26 | -0.20 |
2021-12-31 | -0.08 | -0.05 |
2021-09-30 | -0.16 | -0.11 |
2021-06-30 | ||
2021-03-31 | -0.33 | -0.23 |
2020-12-31 | -0.17 | -0.12 |
2020-09-30 | -0.18 | -0.12 |
Efektivitas Manajemen
- roa untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.21.
- roe untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.22.
- roic untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.25.
- croic untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.05.
- ocroic untuk ESSA Pharma Inc. pada 2025 Jun 30 adalah -0.20.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.21 | -0.22 | -0.25 | -0.05 | -0.20 |
2025-03-31 | -0.23 | -0.23 | -0.26 | 0.49 | -0.19 |
2024-12-31 | -0.20 | -0.20 | -0.23 | 0.56 | -0.18 |
2024-09-30 | -0.19 | -0.19 | -0.21 | 0.37 | -0.18 |
2024-06-30 | -0.17 | -0.18 | -0.21 | 0.35 | -0.17 |
2024-03-31 | -0.16 | -0.16 | -0.18 | -0.11 | -0.16 |
2023-12-31 | -0.16 | -0.16 | -0.18 | -0.16 | -0.14 |
2023-09-30 | -0.16 | -0.16 | -0.18 | -0.20 | -0.16 |
2023-06-30 | -0.16 | -0.17 | -0.18 | -0.20 | -0.16 |
2023-03-31 | -0.18 | -0.18 | -0.19 | -0.27 | -0.17 |
2022-12-31 | -0.18 | -0.18 | -0.21 | -0.48 | -0.17 |
2022-09-30 | -0.19 | -0.19 | -0.21 | -0.48 | -0.17 |
2022-06-30 | -0.18 | -0.19 | -0.22 | -0.45 | -0.16 |
2022-03-31 | -0.19 | -0.19 | -0.21 | -0.36 | -0.16 |
2021-12-31 | -0.48 | -0.50 | -0.21 | 0.36 | -0.13 |
2021-09-30 | -0.41 | -0.41 | -0.19 | 0.42 | -0.11 |
2021-06-30 | -0.86 | -0.89 | -0.16 | 0.54 | -0.11 |
2021-03-31 | -0.69 | -0.72 | -0.14 | 0.54 | -0.09 |
2020-12-31 | -0.54 | -0.55 | -0.34 | 0.09 | -0.24 |
2020-09-30 | -0.43 | -0.48 | -0.30 | 0.04 | -0.21 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1633932 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |